Literature DB >> 23095776

Advanced cytoreductive surgery workshop report.

Krishnansu S Tewari1.   

Abstract

The Advanced Course in Cytoreductive Surgery for Ovarian Cancer and Gynecologic Peritoneal Surface Malignancies was held at the University of California Irvine Medical Center on November 4-5, 2011. The course director was Dr Robert E. Bristow, the Philip J. DiSaia Chair and Division Director of Gynecologic Oncology. Meeting information was distributed via e-mail blasts by the International Gynecologic Cancer Society. The workshop was comprised of didactic modules, a cadaver laboratory, and heated intraperitoneal chemotherapy demonstration. This was a not-for-profit workshop, and registration fees were used to support course faculty travel to UC Irvine and pay for the cadavers.

Entities:  

Mesh:

Year:  2012        PMID: 23095776     DOI: 10.1097/IGC.0b013e3182738338

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  3 in total

1.  Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study.

Authors:  K S Tewari; J J Java; R N Eskander; B J Monk; R A Burger
Journal:  Ann Oncol       Date:  2015-10-20       Impact factor: 32.976

2.  Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies.

Authors:  Krishnansu S Tewari
Journal:  Gynecol Oncol Res Pract       Date:  2016-10-24

3.  Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.

Authors:  Cécile Le Page; Kurosh Rahimi; Martin Köbel; Patricia N Tonin; Liliane Meunier; Lise Portelance; Monique Bernard; Brad H Nelson; Marcus Q Bernardini; John M S Bartlett; Dimcho Bachvarov; Walter H Gotlieb; Blake Gilks; Jessica N McAlpine; Mark W Nachtigal; Alain Piché; Peter H Watson; Barbara Vanderhyden; David G Huntsman; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.